Asparaginase Erwinia Chrysanthemi

Summarized by Plex Health
Last Updated: 02 May 2022

Erwinaze is used to deal with acute lymphoblastic leukemia in adults and children at least 1 years of age. Rylaze is used to deal with lymphoblastic lymphoma in adults and children at least 1 month old who have become adverse other forms of asparaginase such as Elspar or Oncaspar. You might need a pregnancy test to make certain you are not pregnant. Asparaginase Erwinia chrysanthemi can make hormone birth control less efficient, consisting of birth control tablets, injections, implants, skin patches, and vaginal rings. Your blood will require to be tested often and your dosage or drug timetable may be altered based on the results. Store mixed medicine at space temperature level and use it within 4 hrs. Asparaginase erwinia chrysanthemi is additionally being studied in the treatment of other types of cancer. Meaning from the NCI Drug Dictionary, Detailed scientific definition and other names for this medication. If they can help treat or prevent problems other than the ones they are approved for, drugs are typically researched to locate out. This patient info sheet applies only to authorized uses of the medicine. Nonetheless, much of the information might relate to unauthorized uses that are being studied. Discover Clinical Trials for Asparaginase Erwinia Chrysanthemi, Check for trials from NCI's listing of cancer scientific tests now approving patients. The activity of asparaginase erwinia chrysanthemi -rywn is revealed in units, defined as the amount of enzyme that catalyzes the conversion of 1 mol of L-asparagine per response minute, per mg of protein. Each 0. 5 mL has 10 mg asparaginase erwinia chrysanthemi -rywn and the inactive active ingredients: polysorbate 80, salt chloride, sodium phosphate dibasic anhydrous, sodium phosphate monobasic monohydrate, and trehalose.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
CIDMolecularFormulaMolecularWeightCanonicalSMILESIsomericSMILESInChIInChIKeyIUPACNameXLogPExactMassMonoisotopicMassTPSAComplexityChargeHBondDonorCountHBondAcceptorCountRotatableBondCountHeavyAtomCountIsotopeAtomCountAtomStereoCountDefinedAtomStereoCountUndefinedAtomStereoCountBondStereoCountDefinedBondStereoCountUndefinedBondStereoCountCovalentUnitCount
134449732C54H40N2O2748.9C=CC=CC(=C)N(C1=CC=C(C=C1)C2CC=CC(=C2)C3=CC=C(C=C3)N(C4=CC=CC=C4)C5=CC=CC6=C5OC7=CC=CC=C67)C8=CC=CC9=C8OC1=CC=CC=C91C=C/C=C\C(=C)N(C1=CC=C(C=C1)C2CC=CC(=C2)C3=CC=C(C=C3)N(C4=CC=CC=C4)C5=CC=CC6=C5OC7=CC=CC=C67)C8=CC=CC9=C8OC1=CC=CC=C91InChI=1S/C54H40N2O2/c1-3-4-15-37(2)55(49-24-13-22-47-45-20-8-10-26-51(45)57-53(47)49)43-32-28-38(29-33-43)40-16-12-17-41(36-40)39-30-34-44(35-31-39)56(42-18-6-5-7-19-42)50-25-14-23-48-46-21-9-11-27-52(46)58-54(48)50/h3-15,17-36,40H,1-2,16H2/b15-4-KVWJECKFZPINBW-TVPGTPATSA-NN-[4-[3-[4-[dibenzofuran-4-yl-[(3Z)-hexa-1,3,5-trien-2-yl]amino]phenyl]cyclohexa-1,5-dien-1-yl]phenyl]-N-phenyldibenzofuran-4-amine15.1748.308978523748.30897852332.81490004105801011101
*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.

logo

Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.